德西塔的细胞毒性是由dCMP除氨酶DCTD促进的,并由SUMO依赖的E3酶TOPORS减轻
Christopher J Carnie1,2, Maximilian J Götz3, Chloe S Palma-Chaundler4
1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. chris.carnie@cruk.cam.ac.uk.
The EMBO journal
|May 17, 2024
概括
癌症中的德西塔 (5-aza-dC) 耐药性与DCTD有关,这表明其代谢物是细胞毒性. 这项研究确定TOPORS是DNA-蛋白质交叉连接修复因子,对于decitabine疗效至关重要.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 分子药理学分子药理学
背景情况:
- 德西塔 (5-aza-dC) 是一种用于治疗血液癌症的核酸相似物.
- 将其纳入DNA导致DNA甲基转移酶1的DNA-蛋白交叉链接 (DNMT1-DPCs) 和低甲基化.
- 对于decitabine的临床结果各不相同,经常复发,需要对敏感性因素进行研究.
研究的目的:
- 通过基因组规模的CRISPR/Cas9屏幕来识别影响德西他宾敏感性的因素.
- 阐明底层抗素耐药性的机制,并确定新的治疗点.
主要方法:
- 基因组规模的CRISPR/Cas9选用于绘制西敏感性决定因素的图.
- 在DCTD缺乏的细胞中进行遗传查.
- 在DNMT1-DPCs附近的蛋白质的蛋白质识别.
主要成果:
- 丢失dCMP脱氨酶 (DCTD) 赋予了对decitabine的耐药性,表明5-aza-dUMP生成是细胞毒性.
- TOPORS是一种全方位素和SUMO1 E3结合酶,被确定为一种新的DNA-蛋白交联 (DPC) 修复因子.
- TOPORS有助于SUMOylated DNMT1-DPCs的降解. 这一过程中,
结论:
- 当DPC修复受损时,由德胺诱导的DPCs会引起细胞毒性.
- 野生型细胞中的细胞毒性可能源于受损的核酸代谢.
- 这些发现可能有助于开发用于德西治疗的预测生物标志物.
相关概念视频
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


